Synthetic Genomics is now Viridos.Click to see how algae moves us

Tina S. Nova, Ph.D.

Tina S. Nova, Ph.D.

Tina Nova has served as President and Chief Executive Officer (CEO) of Molecular Stethoscope, a diagnostics company, since 2015, and previously was Senior Vice President and General Manager of Illumina’s oncology business unit. Tina was a co-founder of Genoptix, a medical laboratory diagnostics company, and served as its President through 2014. She also served as the company’s CEO and as a member of its board of directors from 2000 until Novartis AG acquired Genoptix in 2011.

Tina was a co-founder of Nanogen, a provider of molecular diagnostic tests, and served as its Chief Operating Officer and President from 1994 to 2000. She previously served as Chief Operating Officer of Selective Genetics, a biotechnology company, and held various positions with Ligand Pharmaceuticals and Hybritech.

Tina serves as the Chair of the Board of Directors for Arena Pharmaceuticals and as a member of the Board of Directors of Veracyte, a diagnostics company. Tina received a B.S. in Biological Sciences from the University of California, Irvine, and a Ph.D. in Biochemistry from the University of California, Riverside.rside.